Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michail Vikelis

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Pain Management|March 20, 2014
Sumatriptan iontophoretic transdermal system for the acute treatment of migraineMichail Vikelis, Dimos D Mitsikostas, Alan M Rapoport
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 16, 2018
A new era in headache treatmentMichail Vikelis, Konstantinos C Spingos, Alan M Rapoport
Neuropsychiatric Disease and Treatment|October 12, 2012
Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraineMichail Vikelis, Dimos D Mitsikostas, Alan M Rapoport
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 31, 2009
The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic studyKostas Konstantopoulos, Michail Vikelis, John Anthony Seikel, et al.
Headache|May 1, 2020
Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-AnalysisIoannis Liampas, Vasileios Siokas, Alexandros Brotis, et al.
Toxins|December 22, 2022
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic MigraineAndreas A Argyriou, Emmanouil V Dermitzakis, Georgia Xiromerisiou, et al.
Pharmacoeconomics - Open|February 22, 2018
Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) QuestionnaireTheodora Oikonomidi, Michail Vikelis, Artemios Artemiadis, et al.
Expert Review of Neurotherapeutics|November 27, 2020
Recently available and emerging therapeutic strategies for the acute and prophylactic management of cluster headache: a systematic review and expert opinionAndreas A Argyriou, Michail Vikelis, Elisa Mantovani, et al.
Acta Neurologica Scandinavica|February 16, 2022
Long-term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxisAndreas A Argyriou, Emmanouil V Dermitzakis, George S Vlachos, et al.
Toxins|July 25, 2022
Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic MigraineEmmanouil V Dermitzakis, Michail Vikelis, George S Vlachos, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Pain Management|March 20, 2014
Sumatriptan iontophoretic transdermal system for the acute treatment of migraineMichail Vikelis, Dimos D Mitsikostas, Alan M Rapoport
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 16, 2018
A new era in headache treatmentMichail Vikelis, Konstantinos C Spingos, Alan M Rapoport
Neuropsychiatric Disease and Treatment|October 12, 2012
Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraineMichail Vikelis, Dimos D Mitsikostas, Alan M Rapoport
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 31, 2009
The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic studyKostas Konstantopoulos, Michail Vikelis, John Anthony Seikel, et al.
Headache|May 1, 2020
Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-AnalysisIoannis Liampas, Vasileios Siokas, Alexandros Brotis, et al.
Toxins|December 22, 2022
OnabotulinumtoxinA Add-On to Monoclonal Anti-CGRP Antibodies in Treatment-Refractory Chronic MigraineAndreas A Argyriou, Emmanouil V Dermitzakis, Georgia Xiromerisiou, et al.
Pharmacoeconomics - Open|February 22, 2018
Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) QuestionnaireTheodora Oikonomidi, Michail Vikelis, Artemios Artemiadis, et al.
Expert Review of Neurotherapeutics|November 27, 2020
Recently available and emerging therapeutic strategies for the acute and prophylactic management of cluster headache: a systematic review and expert opinionAndreas A Argyriou, Michail Vikelis, Elisa Mantovani, et al.
Acta Neurologica Scandinavica|February 16, 2022
Long-term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxisAndreas A Argyriou, Emmanouil V Dermitzakis, George S Vlachos, et al.
Toxins|July 25, 2022
Prospective Comparison of Longer Needle Lengths to Assess the Risk of OnabotulinumtoxinA-Associated Neck Pain in Patients with Chronic MigraineEmmanouil V Dermitzakis, Michail Vikelis, George S Vlachos, et al.
Pageof 7